Skip to Content
  • Previous Rank-
  • Revenues ($M)$2,488.70
  • Revenue Percent Change46.2%
  • Profits ($M)$263.5
  • Profits Percent Change-
  • Assets ($M)$3,546.00
  • Employees2,300
  • Market Value — as of March 29, 2018 ($M)$41,379.30
Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
Jeffrey M. Leiden
CEO Title
Chairman, President & Chief Executive Officer
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
Boston
Websitehttp://www.vrtx.com
Years on Fortune 500 List-
Employees2,300

Vertex Pharmaceuticals Rank History

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$2,488.7046.2%
Profits ($M)$263.5-
Assets ($M)$3,546.00-
Total Stockholder Equity ($M)$2,028.60-
Market Value — as of March 29, 2018 ($M)$41,379.30-

Profit Ratios

Profit as % of Revenues10.6%
Profits as % of Assets7.4%
Profits as % of Stockholder Equity13%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)1.04
EPS % Change (from 2016)-
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-

Total Return

Total Return to Investors (2017)103.4%
Total Return to Investors (5 year, annualized)29%
Total Return to Investors (10 year, annualized)20.5%